Glenmark Pharmaceuticals standalone net profit rises 46.73% in the June 2018 quarter

Sales rise 3.46% to Rs 1563.23 crore

Net profit of Glenmark Pharmaceuticals rose 46.73% to Rs 397.39 crore in the quarter ended June 2018 as against Rs 270.84 crore during the previous quarter ended June 2017. Sales rose 3.46% to Rs 1563.23 crore in the quarter ended June 2018 as against Rs 1510.93 crore during the previous quarter ended June 2017. ParticularsQuarter EndedJun. 2018Jun. 2017% Var.Sales1563.231510.93 3 OPM %26.2523.36 -PBDT528.78349.79 51 PBT495.36319.85 55 NP397.39270.84 47

Powered by Capital Market - Live News